001     872748
005     20210130004259.0
024 7 _ |a 10.1073/pnas.1905955116
|2 doi
024 7 _ |a 0027-8424
|2 ISSN
024 7 _ |a 1091-6490
|2 ISSN
024 7 _ |a 2128/23873
|2 Handle
024 7 _ |a altmetric:71954679
|2 altmetric
024 7 _ |a pmid:31796589
|2 pmid
024 7 _ |a WOS:000503281500070
|2 WOS
037 _ _ |a FZJ-2020-00226
082 _ _ |a 500
100 1 _ |a Haupeltshofer, Steffen
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Smad7 in intestinal CD4 + T cells determines autoimmunity in a spontaneous model of multiple sclerosis
260 _ _ |a Washington, DC
|c 2019
|b National Acad. of Sciences
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1579101412_8097
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Environmental triggers acting at the intestinal barrier are thought to contribute to the initiation of autoimmune disorders. The transforming growth factor beta inhibitor Smad7 determines the phenotype of CD4+ T cells. We hypothesized that Smad7 in intestinal CD4+ T cells controls initiation of opticospinal encephalomyelitis (OSE), a murine model of multiple sclerosis (MS), depending on the presence of gut microbiota. Smad7 was overexpressed or deleted in OSE CD4+ T cells to determine the effect on clinical progression, T cell differentiation, and T cell migration from the intestine to the central nervous system (CNS). Smad7 overexpression worsened the clinical course of OSE and increased CNS inflammation and demyelination. It favored expansion of intestinal CD4+ T cells toward an inflammatory phenotype and migration of intestinal CD4+ T cells to the CNS. Intestinal biopsies from MS patients revealed decreased transforming growth factor beta signaling with a shift toward inflammatory T cell subtypes. Smad7 in intestinal T cells might represent a valuable therapeutic target for MS to achieve immunologic tolerance in the intestine and suppress CNS inflammation.
536 _ _ |a 553 - Physical Basis of Diseases (POF3-553)
|0 G:(DE-HGF)POF3-553
|c POF3-553
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Leichsenring, Teresa
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Berg, Sarah
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Pedreiturria, Xiomara
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Joachim, Stephanie C.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Tischoff, Iris
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Otte, Jan-Michel
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Bopp, Tobias
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Fantini, Massimo C.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Esser, Charlotte
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Willbold, Dieter
|0 P:(DE-Juel1)132029
|b 10
|u fzj
700 1 _ |a Gold, Ralf
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Faissner, Simon
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Kleiter, Ingo
|0 0000-0002-8249-4408
|b 13
|e Corresponding author
773 _ _ |a 10.1073/pnas.1905955116
|g Vol. 116, no. 51, p. 25860 - 25869
|0 PERI:(DE-600)1461794-8
|n 51
|p 25860 - 25869
|t Proceedings of the National Academy of Sciences of the United States of America
|v 116
|y 2019
|x 1091-6490
856 4 _ |y Published on 2019-12-03. Available in OpenAccess from 2020-06-03.
|u https://juser.fz-juelich.de/record/872748/files/Smad7%20in%20intestinal%20CD4%2B%20T%20cells%20determines%20autoimmunity%20in%20a%20spontaneous%20model%20of%20multiple%20sclerosis.pdf
856 4 _ |y Published on 2019-12-03. Available in OpenAccess from 2020-06-03.
|x pdfa
|u https://juser.fz-juelich.de/record/872748/files/Smad7%20in%20intestinal%20CD4%2B%20T%20cells%20determines%20autoimmunity%20in%20a%20spontaneous%20model%20of%20multiple%20sclerosis.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:872748
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 10
|6 P:(DE-Juel1)132029
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v Physical Basis of Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b P NATL ACAD SCI USA : 2017
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b P NATL ACAD SCI USA : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21